{"trigger": ["Conclusions", ""], "relation": []}
{"trigger": ["We have detected a more pronounced production of <extra_id_0> IL-17 <extra_id_2> Protein <extra_id_1> from RA PBMC in response to <extra_id_0> IL-15 <extra_id_2> Protein <extra_id_1> and <extra_id_0> MCP-1 <extra_id_2> Protein <extra_id_1> as well as stimulation by anti-CD3 / anti - <extra_id_0> CD28 <extra_id_2> Protein <extra_id_1> .", ""], "relation": []}
{"trigger": ["We have also shown that upregulation of <extra_id_0> IL-17 <extra_id_2> Protein <extra_id_1> by activated T cells in patients with RA could be the result of activation via the PI3K / <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> pathway with resultant NF-kappaB activation .", ""], "relation": []}
{"trigger": ["Our data provide insights into cellular mechanisms of the regulation of <extra_id_0> IL-17 <extra_id_2> Protein <extra_id_1> production in RA , and highlight the role of T cells , which has hitherto been neglected in RA pathogenesis .", ""], "relation": []}
{"trigger": ["Together with recent data on the successful introduction of anti - <extra_id_0> IL-17 <extra_id_2> Protein <extra_id_1> in RA , our results have added information for the future molecular targeting of new therapeutic applications in RA .", ""], "relation": []}
